Archives

Okklo Life Sciences B.V. (Nijmegen, The Netherlands) and SolAeroMed Inc.  (Calgary, Canada) have signed an agreement to join forces in the field of cyclodextrins and pulmonary diseases. The collaboration aims to optimize the development of novel cyclodextrins for the treatment of cystic fibrosis. In this partnership SolAeroMed will test proprietary cyclodextrins designed by Okklo for …